Journal profile · Chemistry-Electrochemistry
Journal of Pharmaceutical Analysis
ISSN 2095-1779 · eISSN 2214-0883 · Xi'an Jiaotong University · Netherlands
Journal of Pharmaceutical Analysis: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 11.05; fully open access; APC about USD 1,950; median 181 days to acceptance (103 articles, last 24 months); 285 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Pharmaceutical Analysis is published by Xi'an Jiaotong University and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Analytical Chemistry and Chromatography, Analytical Methods in Pharmaceuticals and Metabolomics and Mass Spectrometry Studies, together about 24.1% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Journal of the Xi'an Jiaotong UniversityJournal of Pharmaceutical Analysis (JPA), launched in 2011, is an official journal of the Xi'an Jiaotong University.JPA is a monthly peer-reviewed open access journal that publishes significant Original research articles, Review papers, Short communications, News, Research highlights, and Editorials in the field of Analysis of Pharmacy, broadly covering Pharmaceutical analysis, Analytical techniques and methods, Pharmacology, Metabolism, Drug delivery, Cellular imaging & analysis, Natural products and Biosensing.Other analytical areas that JPA is interested in are: Biology, Nanotechnology, Pharmacognosy, Medicinal chemistry, Clinical laboratory analysis and Artificial intelligence.JPA has a distinguished editorial board with extensive academic qualifications, ensuring that every issue of the journal contains cutting-edge articles on the developments in the field of Analysis of Pharmacy.
From the journal's Aims & Scope
Research area (LetPub): Chemistry-Electrochemistry
Editor-in-chief Langchong HePublisher website
Editorial board by country: 29 in mainland China (about 43%); most named Mainland China 29, United States 6, Germany 3, Italy 3, Canada 3 (68 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Analytical Chemistry and ChromatographyChemistry10.3%
- Analytical Methods in PharmaceuticalsChemistry7.7%
- Metabolomics and Mass Spectrometry StudiesBiochemistry, Genetics and Molecular Biology6.2%
- Computational Drug Discovery MethodsComputer Science6%
- Educational Robotics and EngineeringComputer Science5.7%
- Traditional Chinese Medicine AnalysisMedicine5.6%
- Human auditory perception and evaluationEngineering5.5%
- Antibiotics Pharmacokinetics and EfficacyMedicine4.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Pharmacology & Pharmacy | Zone 1 |
Top journal: yesReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Pharmacology & Pharmacy | Zone 1 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Pharmacology & Pharmacy | Zone 2 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 11.05LetPub ·
- Impact factor (publisher)
- 11.2Publisher website ·
- CiteScore 2026-06
- 12LetPub ·
- CiteScore (publisher)
- 12Publisher website ·
- SJR 2026-06
- 1.59LetPub ·
- SNIP 2026-06
- 1.68LetPub ·
- h-index
- 83OpenAlex ·
- i10-index
- 914OpenAlex ·
- 2-year mean citedness
- 6.66OpenAlex ·
- Self-citation rate
- 1.8%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 210LetPub ·
Articles by year OpenAlex count · 1,740 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 207 | 207 | 78 |
| 2025 | 285 | 285 | 1,465 |
| 2024 | 213 | 213 | 3,155 |
| 2023 | 185 | 185 | 4,455 |
| 2022 | 62 | 62 | 1,728 |
| 2021 | 91 | 91 | 3,070 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
181 daysMedian, submission to acceptance · P25–P75 141 days – 223 days
- Acceptance to online
- median 1 days (103 articles)
- Submission to online
- median 182 days
- Sample
- 103 articles with submission and acceptance dates (460 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 22 weeksLetPub ·
- Submission to first decision
- 3 daysPublisher website ·
- Submission to acceptance
- 153 daysPublisher website ·
- Submission to publication (journal-reported)
- about 47 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 1,950 | Yes | CC BY, CC BY-NC-ND | |
| OpenAlex | USD 1,950 / EUR 1,780 / GBP 1,560 / JPY 241,860 | — | — | |
| LetPub | USD 1,800 | Yes | — | |
| Publisher website | USD 1,950 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers1, by deadline
Publisher websiteWhat to prepare1 items from the author guidelines
- Reference style
- Numbered, in order of citation
Article types accepted9
- commentContributions falling into the following categories will be considered for publication: Original research article, Review paper, Perspective, Short communicatio…Length not stated
- editorialContributions falling into the following categories will be considered for publication: Original research article, Review paper, Perspective, Short communicatio…Length not stated
- newsContributions falling into the following categories will be considered for publication: Original research article, Review paper, Perspective, Short communicatio…Length not stated
- original research articleContributions falling into the following categories will be considered for publication: Original research article, Review paper, Perspective, Short communicatio…Length not stated
- perspectiveContributions falling into the following categories will be considered for publication: Original research article, Review paper, Perspective, Short communicatio…Length not stated
- research highlightContributions falling into the following categories will be considered for publication: Original research article, Review paper, Perspective, Short communicatio…Length not stated
- reviewContributions falling into the following categories will be considered for publication: Original research article, Review paper, Perspective, Short communicatio…Length not stated
- review paperContributions falling into the following categories will be considered for publication: Original research article, Review paper, Perspective, Short communicatio…Length not stated
- short communicationContributions falling into the following categories will be considered for publication: Original research article, Review paper, Perspective, Short communicatio…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI in scientific writing
Generative AI use must be declared Model summary
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Author contributions
For transparency, we require corresponding authors to provide co-author contributions to the manuscript using the relevant CRediT roles. The CRediT taxonomy includes 14 different roles describing each contributor's specific contribution to the scholarly output. The roles are: Conceptualization; Data curation; Formal analysis; Funding acquisition; Investigation; Methodology; Project administration;…
Source ↗Publisher website ·- Conflicts of interest Declaration of interest
Declaration of interest required Model summary
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in two places:…
Source ↗Publisher website ·- License & copyright Copyright
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (for more information on this and copyright, see https://www.elsevier.com/copyright). An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.Author rightsAs an author …
Source ↗Publisher website ·- Open access Open access
Please visit our Open Access page for more information about open access publishing in this journal.
Source ↗Publisher website ·- Peer review Peer review
Double anonymized peer review Model summary
This journal operates a double anonymized review process. All contributions will be initially assessed by the editor for suitability for the journal. Papers deemed suitable are then typically sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor'…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing allowed Model summary
Please note that preprints can be shared anywhere at any time, in line with Elsevier's sharing policy. Sharing your preprints e.g. on a preprint server will not count as prior publication (see 'Multiple, redundant or concurrent publication' for more information).
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Xi'an Jiaotong University
- Country or region
- Netherlands
- Language
- English
- ISSN
- 2095-1779
- Electronic ISSN
- 2214-0883
- Society / sponsor
- Xi'an Jiaotong University
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Journal of Pharmaceutical Analysis
What CAS zone is Journal of Pharmaceutical Analysis in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Pharmaceutical Analysis is in Zone 1 of Medicine, and in Zone 1 of the minor category Pharmacology & Pharmacy; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Pharmaceutical Analysis?
The latest impact factor listed by LetPub is 11.05; CiteScore 12, h-index 83.
How long does peer review take at Journal of Pharmaceutical Analysis?
Based on the dates recorded on 103 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 181 days (interquartile range 141–223 days); authors report an average review time of about 22 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Journal of Pharmaceutical Analysis based?
Of the 68 board members whose country the journal's board page names, 29 (about 43%) are in mainland China; the countries named most often are Mainland China (29), United States (6) and Germany (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of Pharmaceutical Analysis?
According to LetPub and DOAJ records, Journal of Pharmaceutical Analysis is indexed in SCIE, Scopus and DOAJ.
Is Journal of Pharmaceutical Analysis open access, and what is the APC?
Journal of Pharmaceutical Analysis is a fully open-access journal. APC about USD 1,950.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .